Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 39Rectal Neoplasms 11Colonic Neoplasms 11Neoplasms 10Neoplasm Metastasis 9Stomach Neoplasms 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Pancreatic Neoplasms 2Lung Neoplasms 2Adenocarcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Exanthema 1Colorectal Cancer Metastatic 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Carcinoma, Basal Cell 1Carcinoma 1Breast Neoplasms 1Advanced Cancer 1

Interventions

Irinotecan 5aflibercept 4Leucovorin 4Fluorouracil 4Cetuximab 3Bevacizumab 3regorafenib 2Oxaliplatin 2tremelimumab 1monoclonal antibody YYB-101 1masitinib 1durvalumab 1Vemurafenib 1Spectrum Analysis, Raman 1Pemetrexed 1Panitumumab 1Nivolumab 1Maraviroc 1Ipilimumab 1Indocyanine Green 1IFL protocol 1Hepatectomy 1Gemcitabine 1Drug Therapy 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colorectal Cancer Metastatic × IFL protocol × Clear all
NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Sanofi

Phase 3 Completed
781 enrolled 28 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡